×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Worldwide schedules comment Share

Online – Live Broadcast: Transpyrenean Oncogynae Symposium Day#2

Chaired by: Martina Ángeles & Véronique D’Hondt

Join us for a high-impact webinar dedicated to the latest advances in ovarian cancer management. This session will explore cutting-edge molecular insights, evolving surgical approaches, and real-world clinical applications.


PROGRAM OVERVIEW

09:30 - 09:50 | Opening Keynote

The French National Network for Rare Gynecologic Tumors: A Success Story
Isabelle Ray-Coquard
Lessons learned & impact on ovarian cancer treatment


SESSION 1: MOLECULAR LANDSCAPE & PERSONALIZED THERAPIES

09:50 - 10:20 | Moderators: Martina Ángeles & Véronique D’Hondt

Homologous Recombination Deficiency (HRD) Beyond BRCA1/2: A Molecular Journey
- French Perspective – Stanislas Quesada
- Spanish Perspective – Sonia Gatius

Interactive Q&A & Audience Polling

10:20 - 10:45 | Coffee Break & Virtual Exhibition Visit


SESSION 2: SURGICAL APPROACHES & EXPERT CENTERS

10:45 - 11:10 | FOCUS INNOVATION: Surgery for Ovarian Cancer

Expert Centers for Complex Surgeries: French & Spanish Perspectives
- French Perspective – Pierre-Emmanuel Colombo
- Spanish Perspective – Vicente Bebia
- Synthesis & Takeaways – Gwenaël Ferron

Live Q&A with Experts


SESSION 3: MULTIDISCIPLINARY CASE DISCUSSIONS

11:10 - 12:20 | Interactive Tumor Board: Optimal Medico-Surgical Strategies for 1L Treatment

Complex Case Discussions with a Multidisciplinary Panel
- MRI/CT-Scan Analysis – Stéphanie Nougaret
- Pathology & Biomarker Interpretation – Sonia Gatius
- 1L Maintenance Treatment for BRCAness Patients – David García Illescas
- 1L Maintenance Treatment for HRP Patients – Laurence Gladieff
- CHIP & Hyperthermic Intraperitoneal Chemotherapy – Pierre-Emmanuel Colombo
- FIGO IV Disease: Surgical vs. Medical Approaches – Martina Ángeles
- Patient-Centered Care & Quality of Life – Frédéric Fiteni

Live Panel Discussion & Audience Engagement


12:20 - 12:30 | Closing Remarks & Key Takeaways

Summary by the Scientific Committee


 

Shooting date : 2025-03-22
Last update : 2025-03-25

Suggestions

Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
Honolulu : Friday, March 21st 2025 from 02am to 06:30am (GMT+1)
San Francisco : Friday, March 21st 2025 from 04am to 08:30am (GMT+1)
New York : Friday, March 21st 2025 from 07am to 11:30am (GMT+1)
Buenos Aires : Friday, March 21st 2025 from 09am to 01:30pm (GMT+1)
London / Dublin : Friday, March 21st 2025 from 12pm to 04:30pm (GMT+1)
Paris / Berlin : Friday, March 21st 2025 from 01pm to 05:30pm (GMT+1)
Istanbul : Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
Moscou / Dubaï : Friday, March 21st 2025 from 04pm to 08:30pm (GMT+1)
Bangkok : Friday, March 21st 2025 from 07pm to 11:30pm (GMT+1)
Shanghai : Friday, March 21st 2025 from 08pm to 12:30am (GMT+1)
Tokyo : Friday, March 21st 2025 from 09pm to 01:30am (GMT+1)
Sydney : Friday, March 21st 2025 from 10pm to 02:30am (GMT+1)
Wellington : Saturday, March 22nd 2025 from 12am to 04:30am (GMT+1)

Transpyrenean Oncogynae Symposium

Advancing gynecologic oncology: from molecular insights to clinical practice

Share
Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

éclairages du congrès de la SGO

Share
Scroll Up